QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

NEOG

QT76Neogen Corporation
NASDAQ·Healthcare·Medical - Diagnostics & Research·USA
Latest market price
9.31
+0.38+4.26%
OverviewShort InterestFilings
NEOGQT76Neogen Corporation·NASDAQ
OverviewShort InterestFilings
9.31+4.26%
TA
Loading chart...
Screen all →
TMO+0.63%$464.61DHR-0.33%$177.17IDXX+2.93%$562.09A+2.20%$127.06NTRA+2.19%$231.41IQV-1.70%$167.77ILMN+1.79%$161.93WAT-0.44%$355.44
Snapshot
Index-P/E-EPS (ttm)-2.80
Insider Own3.29%
Shs Outstand217.67M
Perf Week0.76%
Market Cap1.94BForward P/E26.60EPS next Y0.35Insider Trans0.04%Shs Float-Perf Month11.50%
Enterprise Value2.58BPEG0.02EPS next Q0.05Inst Own-Short Float-Perf Quarter7.01%
Income-608610122.00P/S2.23EPS this Y110.71%Inst Trans-Short Ratio-Perf Half Y32.24%
Sales870.54MP/B0.92EPS next Y16.67%ROA-18.12%Short Interest-Perf YTD33.19%
Book/sh9.66P/C27.96EPS next 5Y18.56%ROE-29.00%52W High11.43 -18.55%Perf Year76.33%
Cash/sh0.74P/FCF46.53EPS past 3/5Y-ROIC-1.15%52W Low4.56 104.17%Perf 3Y-
Dividend Est.-EV/EBITDA-5.75Sales past 3/5Y19.31% 16.45%Gross Margin42.56%Volatility2.70% 2.78%Perf 5Y-
Dividend TTM-EV/Sales2.96EPS Y/Y TTM766.67%Oper. Margin-4.36%ATR (14)0.36Perf 10Y-
Dividend Ex-Date-Quick Ratio2.84Sales Y/Y TTM-5.84%Profit Margin-69.93%RSI (14)54.35Recom2.50
Dividend Gr. 3/5Y-Current Ratio3.92EPS Q/Q-9.09%SMA202.54%Beta1.54Target Price11.00
Payout0.00%Debt/Eq0.38Sales Q/Q-4.52%SMA502.01%Rel Volume1.98Prev Close8.93
Employees2,917LT Debt/Eq0.43EarningsAug 04SMA20014.95%Avg Volume2.56MPrice9.31
IPO DateAug 23, 1989Option/ShortYes / YesEPS/Sales Surpr.42.86% 8.17%Net Debt/EBITDA-1.41Volume5,065,588Change4.26%
Analyst Ratings
DateActionAnalystRatingTarget
Jan-12-26ReiteratedPiper SandlerNeutral$6.50 → $10
Jan-09-26ReiteratedGuggenheimBuy$12
Dec-10-25UpgradeCJS SecuritiesMarket Perform → Market Outperform
Oct-16-25ReiteratedPiper SandlerNeutral$5.00 → $6.50
Jul-29-25DowngradeWilliam BlairOutperform → Market Perform
Apr-22-25ReiteratedPiper SandlerNeutral$18 → $5.00
Aug-06-24ReiteratedPiper SandlerNeutral$17 → $18
Nov-22-22UpgradeWilliam BlairMarket Perform → Outperform
Mar-19-19UpgradeCraig-HallumHold → Buy
Dec-22-15DowngradeCraig-HallumBuy → Hold
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
5/31/2025
FY 2024
5/31/2024
FY 2023
5/31/2023
FY 2022
5/31/2022
FY 2021
5/31/2021
FY 2020
5/31/2020
FY 2019
5/31/2019
FY 2018
5/31/2018
Total Revenue870895924
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A500473462
Gross Profit371421463
Selling, General and Administrative Excl. Other412402383
Research and Development202122
Other Operating Expense-24-11-20
Operating Income-37977
Interest Expense627273
Unusual Expense
———
Non-Operating Income (Expense)5281,07316
Net Income Before Taxes-627-1,133-14
Income Taxes-19-41-5
Consolidated Net Income-609-1,092-9
Net Income From Continuing Operations-609-1,092-9
Net Income-609-1,092-9
EPS (Recurring)-2.80-5.03-0.04
EPS (Basic, Before Extraordinaries)-2.80-5.03-0.04
EPS (Diluted)-2.80-5.03-0.04
EBITDA-449-938183
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio2.331.42—
Gross Margin42.6447.0450.11
Operating Margin-4.251.018.33
Net Margin-70.00-122.01-0.97
Shares Outstanding218217216
Market Capitalization2,0301,272—
Operating Lease Expense
———
Insider Trading Volume
$9.54$9.04$8.55$8.06$7.56● Close Price0.00K0.38K0.76K1.14K1.52KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Rocklin Amy MFormer Chief Legal OfficerMay 18 '26Option Exercise9.2970,366653,70092,423May 19 12:00 AM
Moylan John PatrickChief Accounting OfficerMay 04 '26Option Exercise9.539,11686,87618,905May 05 12:00 AM
Nassif MikhealCEOFeb 17 '26Buy10.9423252704Feb 17 12:00 AM
Nassif MikhealCEOFeb 02 '26Buy10.0024240681Feb 02 12:00 AM
Nassif MikhealCEOJan 26 '26Buy9.8625246657Feb 02 12:00 AM
Nassif MikhealCEOJan 16 '26Buy9.331371,279632Jan 16 12:00 AM
Naemura David H.Former CFODec 01 '25Option Exercise5.9825,824154,42893,936Dec 02 12:00 AM
Nassif MikhealCEONov 03 '25Buy6.251771,106495Nov 07 12:00 AM
CAPELLO JEFFREY DDirectorOct 27 '25Option Exercise6.197,60447,07032,502Oct 29 12:00 AM
Gupta AashimaDirectorOct 27 '25Option Exercise6.193,55422,00027,790Oct 29 12:00 AM
Green Ronald DDirectorOct 27 '25Option Exercise6.193,55422,00018,654Oct 29 12:00 AM
BOREL JAMES CDirectorOct 27 '25Option Exercise6.197,60447,07096,347Oct 29 12:00 AM
Rocklin Amy MChief Legal OfficerOct 27 '25Option Exercise6.1918,948117,28859,325Oct 28 12:00 AM
RODRIGUEZ RAFAEL ADirectorOct 27 '25Option Exercise6.193,55422,00020,821Oct 28 12:00 AM
Tobin James PDirectorOct 27 '25Option Exercise6.193,55422,00043,347Oct 28 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR